๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Guangzhou
Clinical trial register · China

Clinical Trials in Guangzhou

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University451 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University181 Nanfang Hospital, Southern Medical University138 AstraZeneca133 Guangdong Provincial People's Hospital81
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
3318 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
A Study of HQP1351 in Patients With GIST or Other Solid Tumors
NCT03594422Gastrointestinal Stromal Tumor (GIST), Solid Tumor, Adult
Ascentage Pharma Group Inc.
Phase 1
100
Guangzhou, Zhengzhou, Wuhan, Beijing, Shanghai
2018-07-11
Active, closed
Prediction System of Clinical Endpoint Events for Chronic Hepatitis B Patients
NCT03777969Chronic Hepatitis b
Beijing Friendship Hospital
Observational
2,000
Beijing, Guangzhou, Wuxi, Shanghai, Hangzhou
2018-06-29
Active, closed
Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy
NCT03755791Hepatocellular Carcinoma
Exelixis
Phase 3
837
Hefei, Fuzhou, Xiamen, Guangzhou, Harbin, Zhengzhou, Changsha, Nanjing
2018-06-10
Recruiting
Nanshan Elderly Cohort Study
NCT03569735Hypertension, Type 2 Diabetes Mellitus, Cardiovascular Diseases, Stroke
Sun Yat-sen University
Observational
20,000
Shenzhen, Guangzhou
2018-05-26
Recruiting
Maternal Grandmothers in the Born in Guangzhou Cohort Study
NCT03633162Hereditary Transmission, Immune Development, Childhood Obesity, Host and Microbiome
Guangzhou Women and Children's Medical Center
Observational
5,000
Guangzhou
2018-05-21
Active, closed
The Clinical Cure Project of Chronic Hepatitis B in China
NCT04035837Hepatitis B, Chronic
Third Affiliated Hospital, Sun Yat-Sen University
Phase 4
30,000
Guangzhou
2018-05-16
Active, closed
Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer
NCT03519230Ovarian Cancer
BeiGene
Phase 3
224
Hefei, Beijing, Chongqing, Guangzhou, Shantou, Nanning, Harbin, Zhengzhou
2018-05-14
Recruiting
Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer
NCT04263298Metastatic Breast Cancer
Herui Yao
Phase 3
210
Guangzhou, Shantou, Shenzhen, Zhangjiang, Zhuhai, Nanning, Changsha
2018-05-01
Active, closed
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
NCT03425643Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC
Phase 3
797
Tianjin, Beijing, Guangzhou, Changsha, Shanghai, Xiโ€™an, Hangzhou, Ningbo
2018-04-24
Recruiting
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
NCT03460977Metastatic Castration Resistant Prostate Cancer (mCRPC), Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL)
Pfizer
Phase 1
453
Guangzhou, Changsha, Nanjing, Chengdu, Wenzhou
2018-04-17
Active, closed
Cetuximab Plus FOLFOXIRI vs Cetuximab Plus FOLFOX For CRCLM
NCT03493048Colorectal Cancer, Liver Metastases
Sun Yat-sen University
Phase 2
146
Guangzhou
2018-04-15
Active, closed
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
NCT03466411Crohn's Disease
Janssen Research & Development, LLC
Phase 2/3
1,409
Beijing, Changsha, Changzhou, Chengdu, Chongqing, Ganzhou, Guangzhou, Hangzhou
2018-04-13
Active, closed
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
NCT03105102Crohn's Disease
AbbVie
Phase 3
1,336
Guangzhou, Shijiazhuang, Wuhan, Changsha, Nanchang, Shanghai, Chengdu, Tianjin
2018-04-09
Active, closed
A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations
NCT03390504Urothelial Cancer
Janssen Research & Development, LLC
Phase 3
629
Beijing, Changchun, Chengdu, Chongqing, Guangzhou, Hangzhou, Nanchang, Nanjing
2018-03-23
Active, closed
A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433
NCT03345823Crohn's Disease
AbbVie
Phase 3
747
Beijing, Xiamen, Guangzhou, Wuhan, Changsha, Nanjing, Nanchang, Changchun
2018-03-21
Recruiting
Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes
NCT03264352Diabetes Mellitus, Type 2, Adverse Event, Blood Pressure, Prehypertension
XueQing Yu
Phase 4
11,414
Guangzhou
2018-02-01
Recruiting
Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma
NCT03919552Cisplatin, Carboplatin, NPC
Nanfang Hospital, Southern Medical University
Phase 3
482
Guangzhou
2018-01-31
Active, closed
Radiomics Subtyping to Guide Surgery vs. Maintenance Therapy After HCC Downstaging
NCT07581769Hepatocellular Carcinoma (HCC), Downstaging, Liver Resection, Lenvatinib
First Affiliated Hospital, Sun Yat-Sen University
Observational
500
Guangzhou
2018-01-01
Active, closed
Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy
NCT03315364Recurrent or Metastatic Breast Cancer
Daehwa Pharmaceutical Co., Ltd.
Phase 2/3
549
Hefei, Beijing, Guangzhou, Haikou, Harbin, Zhengzhou, Nanjing, Changchun
2017-12-18
Recruiting
The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research
NCT03158090Acromegaly
Ginkgo Leaf Center for Rare Disorders
Observational
1,965
Guangzhou
2017-12-15
Active, closed
A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
NCT03319667Plasma Cell Myeloma
Sanofi
Phase 3
475
Beijing, Changchun, Fuzhou, Guangzhou, Hangzhou, Nanjing, Shanghai, Shenyang
2017-12-07
Active, closed
TPF+CCRT vs.CCRT+PF in High Risk Nasopharyngeal Carcinoma
NCT03306121Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3
322
Guangzhou
2017-11-13
Recruiting
Simplified Treatment of Anti-retrovirus in China (C-STAR)
NCT03603977HIV/AIDS
Guangzhou 8th People's Hospital
Observational
600
Guangzhou
2017-11-01
Active, closed
Cardiovascular Disease Cohort in Guangdong Province
NCT03351907Cardiovascular Disease
Min Xia
Observational
5,000
Guangzhou
2017-11-01
Active, closed
A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL
NCT03336333Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
BeiGene
Phase 3
590
Hefei, Beijing, Chongqing, Fuzhou, Quanzhou, Guangzhou, Zhengzhou, Wuhan
2017-10-31
Active, closed
A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) Mutation
NCT03182244AML With FLT3 Mutation
Astellas Pharma Inc
Phase 3
276
Beijing, Changchun, Changsha, Fuzhou, Guangzhou, Guiyang, Hangzhou, Hefei
2017-10-25
Active, closed
A Study of Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
NCT02966756Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
AbbVie
Phase 2
66
Hefei, Beijing, Fuzhou, Guangzhou, Shijiazhuang, Zhengzhou, Wuhan, Changsha
2017-10-12
Active, closed
Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma
NCT03298451Hepatocellular Carcinoma
AstraZeneca
Phase 3
1,324
Beijing, Changchun, Changsha, Chengdu, Dalian, Fuzhou, Guangzhou, Hangzhou
2017-10-11
Recruiting
The Effect of Chimeric Antigen Receptor (CAR)-T Cell Therapy on the Reconstitution of HIV-specific Immune Function
NCT03240328HIV/AIDS
Guangzhou 8th People's Hospital
Phase 1
40
Guangzhou
2017-10-04
Recruiting
Endoscopic Nasopharyngectomy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma Patients
NCT03353467Nasopharyngeal Carcinoma, Endoscopic Surgery, Primary Napharyngeal Carcinama, Stage I Nasopharyngeal Cancer
Sun Yat-sen University
Not applicable
228
Guangzhou, Zhongshan, Nanning
2017-10-01
Active, closed
A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)
NCT03178552Non-Small Cell Lung Cancer
Hoffmann-La Roche
Phase 2/3
1,000
Beijing, Changsha, Chengdu, Guangzhou, Hangzhou, Jinan, Nanchang, Nanjing
2017-09-22
Active, closed
Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis
NCT03221036Moderately to Severely Active Ulcerative Colitis
Takeda
Phase 3
392
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Zhangzhou, Guangzhou, Meizhou
2017-08-03
Active, closed
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer
NCT03155997Breast Cancer
Eli Lilly and Company
Phase 3
5,637
Beijing, Fuzhou, Guangzhou, Harbin, Zhengzhou, Changsha, Nanjing, Jinan
2017-07-12
Recruiting
GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression
NCT03198546Hepatocellular Carcinoma, Immunotherapy, CAR, GPC3 Gene Inactivation
Second Affiliated Hospital of Guangzhou Medical University
Phase 1
30
Guangzhou
2017-07-01
Recruiting
iCAGES-guided Precision Therapy for Cancers in Contrast to Standard Care or IHC-guided Theray
NCT03192501Lung Cancer, Gene Abnormality, Gene Product Sequence Variation, Cancer
Second Affiliated Hospital of Guangzhou Medical University
Observational
250
Guangzhou
2017-07-01
Recruiting
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFฮฒ/HER2/Lewis-Y/AXL/EGFR-CAR-T Cells Against Cancers
NCT03198052Lung Cancer, Cancer, Immunotherapy, CAR-T Cell
Second Affiliated Hospital of Guangzhou Medical University
Phase 1
30
Guangzhou
2017-07-01
Active, closed
Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation
NCT03173248Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS), Leukemia, Myeloid, Acute
Institut de Recherches Internationales Servier
Phase 3
146
Zhengzhou, Chengdu, Beijing, Guangzhou, Hangzhou, Tianjin
2017-06-26
Active, closed
Phase II Study of Combined Chemotherapy With Arsenic Trioxide in Stage 4/M Neuroblastoma
NCT03503864Neuroblastoma
Yang Li
Phase 2
80
Guangzhou
2017-06-12
Active, closed
Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).
NCT03164616Non Small Cell Lung Cancer NSCLC
AstraZeneca
Phase 3
1,186
Beijing, Changchun, Changsha, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei
2017-06-01
Recruiting
A Study in Radiotherapy-related Nervous System Complications
NCT03908502Nervous System Complication
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
4,000
Guangzhou
2017-06-01
Active, closed
A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC
NCT03052608Carcinoma, Non-Small-Cell Lung
Pfizer
Phase 3
296
Beijing, Changchun, Shanghai, Hangzhou, Guangzhou
2017-04-27
Recruiting
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
NCT03093116Locally Advanced Solid Tumors, Metastatic Solid Tumors
Turning Point Therapeutics, Inc.
Phase 1/2
500
Beijing, Daping, Fuzhou, Xiamen, Guangzhou, Shenzhen, Harbin, Shatin
2017-03-07
Active, closed
Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NCT03047265Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2
164
Guangzhou
2017-02-04
Active, closed
A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naรฏve Participants With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy
NCT02993523Acute Myeloid Leukemia (AML)
AbbVie
Phase 3
443
Fuzhou, Guangzhou, Shijiazhuang, Zhengzhou, Wuhan, Nanjing, Changchun, Shanghai
2017-02-02
Active, closed
A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)
NCT03006068Ulcerative Colitis (UC)
AbbVie
Phase 3
950
Guangzhou, Shiyan, Wuhan, Changsha, Nanchang, Changchun, Shenyang, Shanghai
2017-01-31
Recruiting
A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors.
NCT06836492Rhabdomyosarcoma, Pediatric Cancer
Yizhuo Zhang
Phase 3
300
Guangzhou
2017-01-30
Active, closed
Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL)
NCT03003962Non Small Cell Lung Carcinoma NSCLC
AstraZeneca
Phase 3
669
Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Haikou
2017-01-02
Active, closed
Cohort Study in South China
NCT03288805Chronic Disease
Min Xia
Observational
110,000
Guangzhou
2017-01-01
Recruiting
China Collaborative Study on Epidemiology of Acute Kidney Injury
NCT03054142Acute Kidney Injury
XinLing Liang
Observational
1,000,000
Guangzhou
2017-01
Active, closed
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer
NCT02763566Breast Cancer
Eli Lilly and Company
Phase 3
463
Bengbu, Beijing, Fuzhou, Guangzhou, Nanning, Shijiazhuang, Harbin, Zhengzhou
2016-12-05
Recruiting
IgA Nephropathy Biomarkers Evaluation Study (INTEREST)
NCT02954419IgA Nephropathy, Glomerular Diseases
Sun Yat-sen University
Observational
2,000
Guangzhou
2016-11
Recruiting
Multicenter Cohort Study on Osteoporosis
NCT02958020Osteoporosis
Shanghai University of Traditional Chinese Medicine
Observational
50,000
Shenzhen, Ganzhou, Jinan, Kunming, Beijing, Changchun, Guangzhou, Lanzhou
2016-11
Recruiting
Clinical and Molecular Studies in Families With Inherited Eye Disease
NCT02771236Inherited Eye Disease
National Eye Institute (NEI)
Observational
5,000
Guangzhou
2016-10-04
Active, closed
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
NCT02864992Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV
EMD Serono Research & Development Institute, Inc.
Phase 2
337
Beijing, Changchun, Changsha, Chengdu, Guangzhou, Hangzhou, Harbin, Hefei
2016-09-13
Active, closed
Personalized Prediction Strategy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease
NCT03240315Pulmonary Disease, Chronic Obstructive
Guangzhou Institute of Respiratory Disease
Observational
442
Guangzhou
2016-08-01
Active, closed
Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY)
NCT02859038Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
Shanghai Gynecologic Oncology Group
Phase 3
489
Guangzhou, Shanghai, Hangzhou, Changsha
2016-08
Recruiting
Tricuspid RegurgitAtion rIsk modeL Study (TRAIL Study)
NCT06926959Tricuspid Regurgitation
Sun Yat-sen University
Observational
3,000
Guangzhou, Jieyang, Shantou, Shenzhen, Zhanjiang, Zhongshan
2016-06-15
Recruiting
MItral Regurgitation Risk Assessment and CLinical modElling
NCT06876883Mitral Insufficiency, Mitral Regurgitation (MR)
Sun Yat-sen University
Observational
2,000
Guangzhou
2016-06-15
Active, closed
eXalt3: Study Comparing X-396 (Ensartinib) to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients
NCT02767804Non-small Cell Lung Cancer
Xcovery Holdings, Inc.
Phase 3
290
Hefei, Beijing, Fuzhou, Guangzhou, Shijiazhuang, Changsha, Wuhan, Nanjing
2016-06
Active, closed
Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer
NCT02609776Non-Small-Cell Lung Cancer
Janssen Research & Development, LLC
Phase 1
751
Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Hefei
2016-05-24
Active, closed
Esthetic and Radiographic Outcomes Following Immediate Implant Placement With Thin or Dehiscence Buccal Bone Wall
NCT03319758Jaw, Edentulous, Partially, Acquired Absence of Single Tooth
Sun Yat-sen University
Not applicable
15
Guangzhou
2016-05
Recruiting
Esthetic, Clinical and Radiographic Outcomes of Immediate and Delayed Implant Placement
NCT02814149Jaw, Edentulous, Partially, Acquired Absence of Single Tooth
Sun Yat-sen University
Not applicable
40
Guangzhou
2016-05
Recruiting
Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer
NCT02966483Rectal Neoplasms Malignant, Surgery
Sun Yat-sen University
Not applicable
1,114
Beijing, Chongqing, Guangzhou, Zhanjiang, Zunyi, Changsha, Hengyang, Changchun
2016-04
Recruiting
Super Chinese Nephrotic Syndrome Registration System (SUCCESS)
NCT03001934Nephrotic Syndrome
Sun Yat-sen University
Observational
5,000
Guangzhou
2016-04
Active, closed
Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer
NCT02455141Breast Neoplasm
Shanghai Jiao Tong University School of Medicine
Phase 3
786
Fuding, Fuzhou, Quanzhou, Foshan, Guangzhou, Harbin, Jiangyin, Suzhou
2016-03
Recruiting
Proximally Extended Resection for Rectal Cancer After Neoadjuvant Chemoradiotherapy
NCT02649647Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
Not applicable
240
Guangzhou
2016-02
Recruiting
Additive Anti-inflammatory Action for Aortopathy & Arteriopathy
NCT04398992Acute Aortic Syndrome
Nanjing Medical University
Observational
10,000
Beijing, Chongqing, Guangzhou, Nanning, Xingyi, Harbin, Changzhou, Suqian
2016-01-01
Recruiting
The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
NCT03368651Hepatocellular Carcinoma
Sun Yat-sen University
Phase 3
230
Guangzhou
2016-01-01
Active, closed
Sentinel Lymph Node Biopsy Versus Pelvic Lymphadenectomy in Early-stage Cervical Cancer (PHENIX/CSEM 010)
NCT02642471Cervical Cancer, Surgery, Quality of Life
Sun Yat-sen University
Not applicable
1,080
Guangzhou
2015-12-31
Active, closed
A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children
NCT02637687Solid Tumors Harboring NTRK Fusion
Bayer
Phase 1/2
154
Beijing, Guangzhou, Tianjin
2015-12-16
Recruiting
Non-risk Based Lang Cancer Screening With a One-off LDCT
NCT04938804Lung Cancer
The First Affiliated Hospital of Guangzhou Medical University
Not applicable
11,000
Guangzhou
2015-12-12
Active, closed
Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study
NCT02584933ALK Positive Malignancies
Novartis Pharmaceuticals
Phase 4
233
Guangzhou, Changchun, Beijing
2015-12-11
Active, closed
A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC
NCT02489318Prostate Cancer
Aragon Pharmaceuticals, Inc.
Phase 3
1,052
Beijing, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Nanjing, Shanghai
2015-11-27
Active, closed
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
NCT02568267Breast Cancer, Cholangiocarcinoma, Colorectal Cancer, Head and Neck Neoplasms
Hoffmann-La Roche
Phase 2
534
Harbin, Wuhan, Chengdu, Beijing, Guangzhou, Hangzhou, Shanghai, Shenzhen
2015-11-19
Active, closed
An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS
NCT02531516Prostatic Neoplasms
Aragon Pharmaceuticals, Inc.
Phase 3
1,503
Beijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Nanchang, Nanjing, Ningbo
2015-11-19
Active, closed
Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE)
NCT02542293Non Small Cell Lung Carcinoma NSCLC
AstraZeneca
Phase 3
953
Beijing, Changchun, Chongqing, Guangzhou, Hangzhou, Shanghai, รœrรผmqi, Wuhan
2015-11-03
Active, closed
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]
NCT02486718Non-Small Cell Lung Cancer
Hoffmann-La Roche
Phase 3
1,280
Beijing, Guangzhou, Hangzhou, Hefei, Shanghai, Shengyang, Shenyang, Suzhou
2015-10-31
Active, closed
AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.
NCT02511106Stage IB-IIIA Non-small Cell Lung Carcinoma
AstraZeneca
Phase 3
682
Beijing, Changchun, Dalian, Guangzhou, Hangzhou, Kunming, Nanjing, Nanning
2015-10-21
Recruiting
China Registry for Genetic / Metabolic Liver Diseases
NCT03131427Genetic/Metabolic Liver Diseases
Beijing Friendship Hospital
Observational
20,000
Beijing, Guangzhou, Shijiazhuang, Zhengzhou, Shanghai, Chengdu, Tianjin, รœrรผmqi
2015-06-13
Active, closed
The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT
NCT02460887Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3
236
Guangzhou
2015-06
Active, closed
FOLFOX or CAPOX Perioperative Chemotherapy Versus Postoperative Chemotherapy for Locally Advanced Colon Cancer (OPTICAL)
NCT02572141Colon Cancer
Sun Yat-sen University
Phase 3
738
Guangzhou
2015-01-01
Active, closed
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
NCT02135042EBV Infection, Stage II Nasopharyngeal Carcinoma AJCC v7, Stage III Nasopharyngeal Carcinoma AJCC v7, Stage IVA Nasopharyngeal Carcinoma AJCC v7
NRG Oncology
Phase 2/3
924
Guangdong Province, Guangzhou
2014-07-01
Recruiting
Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b
NCT02883647Chronic Hepatitis b
Third Affiliated Hospital, Sun Yat-Sen University
Observational
100
Guangzhou
2014-01-01
Recruiting
REal-world Data of CARdiometabolic ProtEcTion
NCT07038083Cardiometabolic Diseases
Sun Yat-sen University
Observational
40,000
Guangzhou
2014-01-01
Recruiting
Peritoneal Dialysis Registration System (PERSIST)
NCT02989298ESRD, Disorders Associated With Peritoneal Dialysis
Sun Yat-sen University
Observational
10,000
Guangzhou
2013-12
Recruiting
Wise Practice of Chinese Hemodialysis (WISHES)
NCT03001921Haemolyses and Related Conditions
Sun Yat-sen University
Observational
30,000
Guangzhou
2013-12
Recruiting
High Quality Evidence of Chinese Lupus Nephritis (HELP)
NCT03001973Lupus Nephritis
Sun Yat-sen University
Observational
5,000
Guangzhou
2013-11
Recruiting
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
Janssen Research & Development, LLC
Phase 3
700
Beijing, Chengdu, Fuzhou, Guangzhou, Hangzhou, Shanghai, Shanxi, Suzhou
2013-09-09
Active, closed
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
NCT01874353Platinum Sensitive, BRCA Mutated, Relapsed Ovarian Cancer, Following Complete or Partial Response to Platinum Based Chemotherapy
AstraZeneca
Phase 3
327
Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Harbin
2013-09-03
Active, closed
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
NCT01844986Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV, BRCA Mutation
AstraZeneca
Phase 3
450
Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Harbin
2013-08-26
Recruiting
Predicting Gastric Cancer Response to Chemo With Multimodal AI Model
NCT06451393Gastric Cancer, Chemotherapy Effect
Sixth Affiliated Hospital, Sun Yat-sen University
Observational
500
Guangzhou
2013-02-01
Recruiting
the National Colorectal Cancer Cohort (NCRCC) Study: National Colorectal Cancer Research Consortium
NCT04074538Colorectal Cancer
Ding Ke-Feng
Observational
55,000
Hangzhou, Beijing, Chengdu, Guangzhou, Shanghai
2013-01-01
Recruiting
Causation And Prognosis Analyses of Coronary Artery Diseases: A Longitudinal Cohort Study
NCT07480512Coronary Artery Disease
Sun Yat-sen University
Observational
30,000
Guangzhou
2013-01-01
Recruiting
Myocardial Protection Effect of Simvastatin Undergoing Cardiac Surgery
NCT01653223Congenital Heart Disease, Heart Valve Disease
Sun Yat-sen University
Not applicable
369
Guangzhou
2013-01
Recruiting
IgA Nephropathy Registration Initiative of High Quality (INSIGHT)
NCT03001947IgA Nephropathy
Sun Yat-sen University
Observational
10,000
Guangzhou
2012-11
Recruiting
A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients Treatment
NCT01994057Non-small Cell Lung Cancer (NSCLC), EGFR-TKI Resistant Mutation, EGFR-TKI Sensitizing Mutation, Germline Mutations
Sun Yat-sen University
Observational
1,000
Guangzhou
2012-09
Recruiting
Preterm Birth Cohort Study in Guangzhou
NCT03668327Preterm Birth, Neurodevelopment, Immune Development, Host and Microbiome
Guangzhou Women and Children's Medical Center
Observational
5,000
Guangzhou
2012-02-01
Recruiting
IVF Offspring Born in Guangzhou
NCT03650829ART, Offspring, Adult, Genetics, Host and Microbiome
Guangzhou Women and Children's Medical Center
Observational
3,000
Guangzhou
2012-02-01
Recruiting
Twins Born in Guangzhou
NCT03331133Twin Diseases, Immune Development, Childhood Obesity, Host and Microbiome
Guangzhou Women and Children's Medical Center
Observational
1,000
Guangzhou
2012-02-01
Recruiting
The Born in Guangzhou Cohort Study (BIGCS)
NCT02526901Intrauterine Hyperglycemia, Pregnancy Outcomes, Neurodevelopment, Immune Development
Guangzhou Women and Children's Medical Center
Observational
30,000
Guangzhou
2012-02-01
Rows per page Showing 3201–3300 of 3318
Previous 31 32 33 34 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china/city/guangzhou?page=33

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.